Summary
25.01 -0.21(-0.81%)05/16/2024
Avantor Inc. (AVTR)
Avantor Inc. (AVTR)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.08 | 2.56 | -3.19 | 4.94 | 35.13 | 23.69 | 0.00 | 71.38 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 24.85 | |
| Open | 24.86 | |
| High | 24.99 | |
| Low | 24.71 | |
| Volume | 3,842,866 | |
| Change | -0.02 | |
| Change % | -0.08 | |
| Avg Volume (20 Days) | 5,717,448 | |
| Volume/Avg Volume (20 Days) Ratio | 0.67 | |
| 52 Week Range | 16.63 - 26.16 | |
| Price vs 52 Week High | -5.01% | |
| Price vs 52 Week Low | 49.43% | |
| Range | -0.04 | |
| Gap Up/Down | -0.07 | |
Fundamentals | ||
| Market Capitalization (Mln) | 17,124 | |
| EBIDTA | 1,396,999,936 | |
| PE Ratio | 48.4577 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 45.37 | |
| Book Value | 5.0890 | |
| Earnings Per Share | 0.7910 | |
| EPS Estimate Current Quarter | 0.3200 | |
| EPS Estimate Next Quarter | 0.3300 | |
| EPS Estimate Current Year | 1.3900 | |
| EPS Estimate Next Year | 1.5400 | |
| Diluted EPS (TTM) | 0.7910 | |
| Revenues | ||
| Profit Marging | 0.0729 | |
| Operating Marging (TTM) | 0.1403 | |
| Return on asset (TTM) | 0.0576 | |
| Return on equity (TTM) | 0.1593 | |
| Revenue TTM | 7,269,400,064 | |
| Revenue per share TTM | 12.4740 | |
| Quarterly Revenue Growth (YOY) | 0.1430 | |
| Quarterly Earnings Growth (YOY) | 2.1400 | |
| Gross Profit (TTM) | 2,080,500,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 48.4577 | |
| Forward PE | 24.9377 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 7.7334 | |
| Revenue Enterprise Value | 4.0095 | |
| EBITDA Enterprise Value | 23.7117 | |
| Shares | ||
| Shares Outstanding | 609,452,992 | |
| Shares Float | 605,363,298 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 1.63 | |
| Institutions (%) | 94.54 | |
05/03 08:05 EST - prnewswire.com
Avantor® to Participate in BofA Securities 2024 Health Care Conference
RADNOR, Pa. , May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m.
Avantor® to Participate in BofA Securities 2024 Health Care Conference
RADNOR, Pa. , May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m.
04/29 13:36 EST - zacks.com
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
04/26 10:57 EST - seekingalpha.com
Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript
Avantor Inc. (NYSE:AVTR ) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Christina Jones – Vice President-Investor Relations Michael Stubblefield – President and Chief Executive Officer Brent Jones – Executive Vice President and Chief Financial Officer Conference Call Participants Michael Ryskin – Bank of America Dan Leonard – UBS Dan Brennan – TD Cowen Luke Sergott – Barclays Vijay Kumar – Evercore ISI Jack Meehan – Nephron Research Doug Schenkel – Wolfe Research Rachel Vatnsdal – JPMorgan Tejas Savant – Morgan Stanley Josh Waldman – Cleveland Research Patrick Donnelly – Citi Operator Good morning. My name is Emily, and I'll be your conference operator today.
Avantor Inc. (AVTR) Q1 2024 Earnings Call Transcript
Avantor Inc. (NYSE:AVTR ) Q1 2024 Earnings Conference Call April 26, 2024 8:00 AM ET Company Participants Christina Jones – Vice President-Investor Relations Michael Stubblefield – President and Chief Executive Officer Brent Jones – Executive Vice President and Chief Financial Officer Conference Call Participants Michael Ryskin – Bank of America Dan Leonard – UBS Dan Brennan – TD Cowen Luke Sergott – Barclays Vijay Kumar – Evercore ISI Jack Meehan – Nephron Research Doug Schenkel – Wolfe Research Rachel Vatnsdal – JPMorgan Tejas Savant – Morgan Stanley Josh Waldman – Cleveland Research Patrick Donnelly – Citi Operator Good morning. My name is Emily, and I'll be your conference operator today.
04/26 06:00 EST - prnewswire.com
Avantor® Reports First Quarter 2024 Results
Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% Net income of $60 million; Adjusted EBITDA of $283 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 Operating cash flow of $142 million; free cash flow of $107 million RADNOR, Pa. , April 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2024.
Avantor® Reports First Quarter 2024 Results
Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% Net income of $60 million; Adjusted EBITDA of $283 million Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 Operating cash flow of $142 million; free cash flow of $107 million RADNOR, Pa. , April 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2024.
04/25 13:55 EST - zacks.com
Is a Surprise Coming for Avantor (AVTR) This Earnings Season?
Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Avantor (AVTR) This Earnings Season?
Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
04/25 12:41 EST - zacks.com
ELV or AVTR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
ELV or AVTR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
04/25 10:36 EST - zacks.com
Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat
Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.
Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat
Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.
04/08 12:41 EST - zacks.com
BLCO vs. AVTR: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
BLCO vs. AVTR: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
04/01 08:00 EST - prnewswire.com
Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024
RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m.
Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024
RADNOR, Pa., April 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m.
03/26 12:31 EST - zacks.com
Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
03/21 12:41 EST - zacks.com
BLCO or AVTR: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
BLCO or AVTR: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
02/26 08:05 EST - prnewswire.com
Avantor® Celebrates Supplier Award Honorees at 2024 European Sales Conference
RADNOR, Pa. and LISBON, Portugal , Feb. 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, recognized supplier excellence across a range of categories and products at its 2024 European Sales Conference in Lisbon, Portugal earlier this month.
Avantor® Celebrates Supplier Award Honorees at 2024 European Sales Conference
RADNOR, Pa. and LISBON, Portugal , Feb. 26, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, recognized supplier excellence across a range of categories and products at its 2024 European Sales Conference in Lisbon, Portugal earlier this month.
02/20 08:25 EST - zacks.com
New Strong Sell Stocks for February 20th
HAFC, AVTR and WHD have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.
New Strong Sell Stocks for February 20th
HAFC, AVTR and WHD have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.
02/20 08:05 EST - prnewswire.com
Avantor® to Participate in the 44th Annual TD Cowen Health Care Conference
RADNOR, Pa. , Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m.
Avantor® to Participate in the 44th Annual TD Cowen Health Care Conference
RADNOR, Pa. , Feb. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston on Tuesday, March 5, 2024, at approximately 10:30 a.m.
02/15 12:21 EST - zacks.com
Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.
Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.
02/14 14:46 EST - seekingalpha.com
Avantor, Inc. (AVTR) Q4 2023 Earnings Call Transcript
Avantor, Inc. (AVTR) Q4 2023 Earnings Call Transcript
Avantor, Inc. (AVTR) Q4 2023 Earnings Call Transcript
Avantor, Inc. (AVTR) Q4 2023 Earnings Call Transcript
02/14 10:37 EST - zacks.com
Compared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
02/14 06:00 EST - prnewswire.com
Avantor® Reports Fourth Quarter and Full Year 2023 Results
Fourth Quarter 2023 Net sales of $1.72 billion, decrease of 4.0%; core organic decline of 4.8% Net income of $98.5 million; Adjusted EBITDA of $302.1 million Diluted GAAP EPS of $0.15; adjusted EPS of $0.25 Operating cash flow of $251.6 million; free cash flow of $201.0 million Full Year 2023 Net sales of $6.97 billion, decrease of 7.3%; core organic decline of 5.2% Net income of $321.1 million; Adjusted EBITDA of $1,309.1 million Diluted GAAP EPS of $0.47; adjusted EPS of $1.06 Operating cash flow of $870.0 million; free cash flow of $723.6 million Adjusted net leverage of 3.9X; repaid approximately $850 million of debt in 2023 RADNOR, Pa. , Feb. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for the fourth quarter and year ended December 31, 2023.
Avantor® Reports Fourth Quarter and Full Year 2023 Results
Fourth Quarter 2023 Net sales of $1.72 billion, decrease of 4.0%; core organic decline of 4.8% Net income of $98.5 million; Adjusted EBITDA of $302.1 million Diluted GAAP EPS of $0.15; adjusted EPS of $0.25 Operating cash flow of $251.6 million; free cash flow of $201.0 million Full Year 2023 Net sales of $6.97 billion, decrease of 7.3%; core organic decline of 5.2% Net income of $321.1 million; Adjusted EBITDA of $1,309.1 million Diluted GAAP EPS of $0.47; adjusted EPS of $1.06 Operating cash flow of $870.0 million; free cash flow of $723.6 million Adjusted net leverage of 3.9X; repaid approximately $850 million of debt in 2023 RADNOR, Pa. , Feb. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for the fourth quarter and year ended December 31, 2023.
02/09 10:21 EST - zacks.com
Curious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Avantor, Inc. (AVTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Curious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Avantor, Inc. (AVTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.